SCHEMBL7697779

SCHEMBL7697779

COc1cccc(OC)c1CNC(=O)C1CCC(Cc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.51
IDO1 P14902 1/20 0.49
TSHR P16473 1/20 0.48
MAPK10 P53779 1/20 0.48
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPT P10636 2/20 0.46
PKM P14618 1/20 0.46
POLB P06746 1/20 0.46
HPGD P15428 1/20 0.46
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
GRIN2B Q13224 1/20 0.45
DRD4 P21917 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695551 1.00 TP53 (0.51) TP53IDO1TSHRMAPK10MTNR1A
SCHEMBL7691193 0.90 HPGD (0.59) TP53TSHRMAPK10HSD17B10MAPT
SCHEMBL7697784 0.90 HPGD (0.59) TP53TSHRMAPK10HSD17B10MAPT
SCHEMBL7697551 0.87 IDO1 (0.51) IDO1POLBKDM4ESMN1; SMN2NPC1
SCHEMBL7698232 0.87 IDO1 (0.51) IDO1POLBKDM4ESMN1; SMN2NPC1
SCHEMBL7692414 0.85 POLB (0.54) IDO1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL7692413 0.85 POLB (0.54) IDO1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL7693070 0.83 LMNA (0.56) IDO1TSHRMAPTPOLBHPGD
SCHEMBL7693074 0.83 LMNA (0.56) IDO1TSHRMAPTPOLBHPGD
SCHEMBL7083207 0.82 IDO1 (0.56) TP53IDO1PKMHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed